In vitro Models of Neurodegenerative Diseases

A Slanzi, G Iannoto, B Rossi, E Zenaro… - Frontiers in cell and …, 2020 - frontiersin.org
Neurodegenerative diseases are progressive degenerative conditions characterized by the
functional deterioration and ultimate loss of neurons. These incurable and debilitating …

Frontotemporal dementia: latest evidence and clinical implications

JJ Young, M Lavakumar, D Tampi… - Therapeutic …, 2018 - journals.sagepub.com
Background: Frontotemporal dementia (FTD) describes a cluster of neurocognitive
syndromes that present with impairment of executive functioning, changes in behavior, and …

[HTML][HTML] Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration

TE Tracy, J Madero-Pérez, DL Swaney, TS Chang… - Cell, 2022 - cell.com
Tau (MAPT) drives neuronal dysfunction in Alzheimer disease (AD) and other tauopathies.
To dissect the underlying mechanisms, we combined an engineered ascorbic acid …

Tau kinetics in neurons and the human central nervous system

C Sato, NR Barthélemy, KG Mawuenyega… - Neuron, 2018 - cell.com
We developed stable isotope labeling and mass spectrometry approaches to measure the
kinetics of multiple isoforms and fragments of tau in the human central nervous system …

[HTML][HTML] ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids

KR Bowles, MC Silva, K Whitney, T Bertucci, JE Berlind… - Cell, 2021 - cell.com
Frontotemporal dementia (FTD) because of MAPT mutation causes pathological
accumulation of tau and glutamatergic cortical neuronal death by unknown mechanisms. We …

DNA methylation signatures of Alzheimer's disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-types

G Shireby, EL Dempster, S Policicchio… - Nature …, 2022 - nature.com
Alzheimer's disease (AD) is a chronic neurodegenerative disease characterized by the
progressive accumulation of amyloid-beta and neurofibrillary tangles of tau in the neocortex …

Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factors

M Ehrlich, S Mozafari, M Glatza… - Proceedings of the …, 2017 - National Acad Sciences
Rapid and efficient protocols to generate oligodendrocytes (OL) from human induced
pluripotent stem cells (iPSC) are currently lacking, but may be a key technology to …

Regenerative stem cell therapy for neurodegenerative diseases: an overview

F Sivandzade, L Cucullo - International journal of molecular sciences, 2021 - mdpi.com
Neurodegenerative diseases resulting from the progressive loss of structure and/or function
of neurons contribute to different paralysis degrees and loss of cognition and sensation. The …

Recapitulation of endogenous 4R tau expression and formation of insoluble tau in directly reprogrammed human neurons

LS Capano, C Sato, E Ficulle, A Yu, K Horie, JS Kwon… - Cell Stem Cell, 2022 - cell.com
Tau is a microtubule-binding protein expressed in neurons, and the equal ratios between 4-
repeat (4R) and 3-repeat (3R) isoforms are maintained in normal adult brain function …

3D culture models of Alzheimer's disease: a road map to a “cure-in-a-dish”

SH Choi, YH Kim, L Quinti, RE Tanzi… - Molecular …, 2016 - Springer
Alzheimer's disease (AD) transgenic mice have been used as a standard AD model for basic
mechanistic studies and drug discovery. These mouse models showed symbolic AD …